1. Home
  2. SLS vs POWW Comparison

SLS vs POWW Comparison

Compare SLS & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • POWW
  • Stock Information
  • Founded
  • SLS 2012
  • POWW 1990
  • Country
  • SLS United States
  • POWW United States
  • Employees
  • SLS N/A
  • POWW N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • POWW Ordnance And Accessories
  • Sector
  • SLS Health Care
  • POWW Industrials
  • Exchange
  • SLS Nasdaq
  • POWW Nasdaq
  • Market Cap
  • SLS 169.6M
  • POWW 161.5M
  • IPO Year
  • SLS N/A
  • POWW N/A
  • Fundamental
  • Price
  • SLS $1.54
  • POWW $1.37
  • Analyst Decision
  • SLS
  • POWW Hold
  • Analyst Count
  • SLS 0
  • POWW 1
  • Target Price
  • SLS N/A
  • POWW $1.50
  • AVG Volume (30 Days)
  • SLS 2.6M
  • POWW 661.2K
  • Earning Date
  • SLS 08-12-2025
  • POWW 05-20-2025
  • Dividend Yield
  • SLS N/A
  • POWW N/A
  • EPS Growth
  • SLS N/A
  • POWW N/A
  • EPS
  • SLS N/A
  • POWW N/A
  • Revenue
  • SLS N/A
  • POWW $44,429,095.00
  • Revenue This Year
  • SLS N/A
  • POWW $123.84
  • Revenue Next Year
  • SLS N/A
  • POWW N/A
  • P/E Ratio
  • SLS N/A
  • POWW N/A
  • Revenue Growth
  • SLS N/A
  • POWW N/A
  • 52 Week Low
  • SLS $0.77
  • POWW $0.95
  • 52 Week High
  • SLS $2.12
  • POWW $2.14
  • Technical
  • Relative Strength Index (RSI)
  • SLS 45.96
  • POWW 38.18
  • Support Level
  • SLS $1.47
  • POWW $1.34
  • Resistance Level
  • SLS $1.73
  • POWW $1.50
  • Average True Range (ATR)
  • SLS 0.11
  • POWW 0.09
  • MACD
  • SLS -0.02
  • POWW 0.00
  • Stochastic Oscillator
  • SLS 19.44
  • POWW 23.08

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About POWW AMMO Inc.

Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.

Share on Social Networks: